Savara to Participate in Three Upcoming Investor Conferences

Author's Avatar
Nov 09, 2022

Savara+Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate at the following investor healthcare conferences: